Own the gold standard ✨ in financial data & analytics

Subscribe for $2
Overview
Profile
Aelis Farma - Stock

Aelis Farma Stock

AELIS.PA
FR0014007ZB4
A3DE66

Price

12.20
Today +/-
+0
Today %
+0 %
P

Aelis Farma Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Aelis Farma, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Aelis Farma from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Aelis Farma’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Aelis Farma. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Aelis Farma’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Aelis Farma’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Aelis Farma’s growth potential.

Aelis Farma Revenue, EBIT and net profit per share

DateAelis Farma RevenueAelis Farma EBITAelis Farma Net Income
2026e4.81 M undefined-11.54 M undefined-21.64 M undefined
2025e12.77 M undefined-3.23 M undefined-12.97 M undefined
2024e55.65 M undefined39.45 M undefined24.31 M undefined
20239.05 M undefined-6.46 M undefined-5.08 M undefined
20223.81 M undefined-8.53 M undefined-14.29 M undefined
20219.08 M undefined2.55 M undefined574,000 undefined
20200 undefined-2.84 M undefined-2.09 M undefined
20190 undefined-2.99 M undefined-3.17 M undefined
20180 undefined-2.63 M undefined-2.7 M undefined

Aelis Farma Stock Ratios

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2018201920202021202220232024e2025e2026e
00093955124
-----66.67200.00511.11-78.18-66.67
---------
000000000
-2-2-22-8-639-3-11
---22.22-266.67-66.6770.91-25.00-275.00
-2-3-20-14-524-12-21
-50.00-33.33---64.29-580.00-150.0075.00
12.4812.4812.4812.4812.512.9000
- - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Aelis Farma Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Aelis Farma is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Aelis Farma provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Aelis Farma's financial health and stability.

Assets

Aelis Farma's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Aelis Farma must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Aelis Farma after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Aelis Farma's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (k)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (k)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (k)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20182019202020212022
-2-3-20-14
00000
00000
-10015-4
00025
00000
00001,000
-3-2-218-13
00000
00000
00000
00000
01,000000
310023
431022
001,00000
00000
00-1209
-3.57-2.92-2.5118.76-13.19
00000

Aelis Farma stock margins

The Aelis Farma margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Aelis Farma. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Aelis Farma.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Aelis Farma's sales revenue. A higher gross margin percentage indicates that the Aelis Farma retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Aelis Farma's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Aelis Farma's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Aelis Farma's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Aelis Farma. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Aelis Farma's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Aelis Farma Margin History

Aelis Farma Gross marginAelis Farma Profit marginAelis Farma EBIT marginAelis Farma Profit margin
2026e0 %-239.98 %-450.26 %
2025e0 %-25.27 %-101.57 %
2024e0 %70.88 %43.67 %
20230 %-71.36 %-56.09 %
20220 %-223.81 %-375.11 %
20210 %28.12 %6.33 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %

Aelis Farma Stock Sales Revenue, EBIT, Earnings per Share

The Aelis Farma earnings per share therefore indicates how much revenue Aelis Farma has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Aelis Farma earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Aelis Farma's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Aelis Farma’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Aelis Farma's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Aelis Farma Revenue, EBIT and net profit per share

DateAelis Farma Sales per ShareAelis Farma EBIT per shareAelis Farma Earnings per Share
2026e0.36 undefined0 undefined-1.63 undefined
2025e0.96 undefined0 undefined-0.98 undefined
2024e4.2 undefined0 undefined1.83 undefined
20230.7 undefined-0.5 undefined-0.39 undefined
20220.3 undefined-0.68 undefined-1.14 undefined
20210.73 undefined0.2 undefined0.05 undefined
20200 undefined-0.23 undefined-0.17 undefined
20190 undefined-0.24 undefined-0.25 undefined
20180 undefined-0.21 undefined-0.22 undefined

Aelis Farma business model

Aelis Farma is one of the most popular companies on Eulerpool.com.

Aelis Farma valuation based on historical P/E ratio, EBIT, and P/S ratio.

Aelis Farma shares outstanding

The number of shares was Aelis Farma in 2023 — This indicates how many shares 12.899 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Aelis Farma earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Aelis Farma's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Aelis Farma’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Aelis Farma's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Aelis Farma.

Aelis Farma Stock Shareholders

%
Name
Stocks
Change
Date
0.21 % Groupama Asset Management27,19913,3069/30/2023
0.09 % Financière Arbevel12,000012/31/2023
0 % DNCA Investments0-9,6973/31/2023
1

Aelis Farma stock: Frequently Asked Questions

What is the P/E ratio of Aelis Farma 2024?

The Aelis Farma P/E ratio is 6.47.

What is the P/S ratio of Aelis Farma 2024?

The Aelis Farma P/S ratio is 2.83.

What is the AlleAktien quality score of Aelis Farma?

The AlleAktien quality score for Aelis Farma is 3/10.

What is the revenue of Aelis Farma 2024?

The expected Aelis Farma revenue is 55.65 M EUR.

How high is the profit of Aelis Farma 2024?

The expected Aelis Farma profit is 24.31 M EUR.

What is the business model of Aelis Farma

No history available for Aelis Farma.

What is the Aelis Farma dividend?

Aelis Farma pays a dividend of 0 EUR distributed over payouts per year.

How often does Aelis Farma pay dividends?

The dividend cannot currently be calculated for Aelis Farma or the company does not pay out a dividend.

What is the Aelis Farma ISIN?

The ISIN of Aelis Farma is FR0014007ZB4.

What is the Aelis Farma WKN?

The WKN of Aelis Farma is A3DE66.

What is the Aelis Farma ticker?

The ticker of Aelis Farma is AELIS.PA.

How much dividend does Aelis Farma pay?

Over the past 12 months, Aelis Farma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aelis Farma is expected to pay a dividend of 0 EUR.

What is the dividend yield of Aelis Farma?

The current dividend yield of Aelis Farma is .

When does Aelis Farma pay dividends?

Aelis Farma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aelis Farma?

Aelis Farma paid dividends every year for the past 0 years.

What is the dividend of Aelis Farma?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aelis Farma located?

Aelis Farma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Aelis Farma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aelis Farma from 7/7/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 7/7/2024.

When did Aelis Farma pay the last dividend?

The last dividend was paid out on 7/7/2024.

What was the dividend of Aelis Farma in the year 2023?

In the year 2023, Aelis Farma distributed 0 EUR as dividends.

In which currency does Aelis Farma pay out the dividend?

The dividends of Aelis Farma are distributed in EUR.

Other fundamentals and analyses of Aelis Farma in the deep dive.

Our stock analysis for Aelis Farma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aelis Farma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.